Sharekhan

Haleos Labs Ltd

Mon 1/12/2025,15:44:36 NSE: HALEOSLABS

₹ 1390.60 -2.90 (-0.21%)
BUY NOW Buy Haleos Labs Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Haleos Labs Ltd

Mon 1/12/2025,16:0:0

Haleos Labs Ltd

Mon 1/12/2025,15:44:36 | NSE : HALEOSLABS

₹ 1390.60-2.90 (-0.21%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1393.50

Previous Close

₹ 1393.50

Volume

3079

Mkt Cap ( Rs. Cr)

₹420.42

High

₹ 1425.00

Low

₹ 1375.00

52 Week High

₹ 1680.00

52 Week Low

₹ 959.80

Book Value Per Share

₹ 621.11

Dividend Yield

0.10

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Haleos Labs Ltd

Your Vote -

Buy

77.27%

Hold

18.18%

Sell

4.55%

77.27%

22 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Haleos Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Haleos Labs - Updates

    26 Nov 2025, 6:49PM HALEOS LABS LIMITED has informed the Exchange regarding 'New Logo'.

  • Haleos Labs - Name Change

    26 Nov 2025, 6:47PM HALEOS LABS LIMITED has informed the Exchange about new Scrip id of the Company pursuant to change in name of the Company.

  • Haleos Labs - New Logo

    25 Nov 2025, 6:22PM New logo pursuant to change in the name of the Company.

  • Haleos Labs - New Scrip ID (HALEOSLABS)

    25 Nov 2025, 5:50PM New Scrip id of the Company pursuant to change in name of the Company.

  • SMS Lifesciences Ind - Name and Symbol Change

    20 Nov 2025, 6:52PM SMSLIFE: Members of the Exchange are hereby informed that the name of SMS Lifesciences India Limited shall be changed to HALEOS LABS LIMITED and symbo

  • SMS Lifesciences Ind - Copy of Newspaper Publication

    12 Nov 2025, 1:46PM SMS Lifesciences India Limited has informed the Exchange about Copy of Newspaper Publication

  • SMS Lifesciences Ind - Newspaper Publication (Financial Results)

    12 Nov 2025, 1:44PM Enclosed - Newspaper advertisement.

  • SMS Lifesciences Ind Q2 net profit down 17.14% at Rs 4.98 cr

    10 Nov 2025, 7:12PM The company reported standalone net profit of Rs 4.98 crore for the quarter ended September 30, 2025 as compared to Rs 6.01 crore in the same period l

  • SMS Lifesciences Ind - Outcome of Board Meeting

    10 Nov 2025, 4:46PM SMS Lifesciences India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

  • SMS Lifesciences Ind - Board Meeting Outcome for For The Meeting Held On November 10, 2025

    10 Nov 2025, 4:38PM Enclosed -- Outcome of 95th Board meeting.

  • SMS Lifesciences Ind - Updates

    6 Nov 2025, 7:07PM SMS Lifesciences India Limited has informed the Exchange regarding 'Temporary Withholding Of Dividend'.

  • SMS Lifesciences Ind - Temporary Withholding Of Dividend

    6 Nov 2025, 7:03PM Dividend payable to shareholders who have not updated their KYC details is withheld and shall be released only upon complying with the KYC norms.

  • SMS Lifesciences Ind - Updates

    5 Nov 2025, 2:04PM SMS Lifesciences India Limited has informed the Exchange regarding 'Report (Special Window) for the month of October 2025.

  • SMS Lifesciences Ind - Report (Special Window)

    5 Nov 2025, 2:02PM Enclosed is the summary for the month of October 2025.

  • SMS Lifesciences Ind - Board Meeting Intimation for 95Th Board Meeting (10.11.2025)

    4 Nov 2025, 4:34PM SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consid

  • SMS Lifesciences Ind has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    17 Oct 2025, 9:10AM As of September 2025, 71.40% is owned by Indian Promoters and 28.59% by Public. <p align=justify> Top five Promoters holding highest number of shares

  • SMS Lifesciences Ind - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Oct 2025, 9:33AM SMS Lifesciences India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • SMS Lifesciences Ind - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Oct 2025, 9:30AM Enclosed -- RTA certificate.

  • SMS Lifesciences Ind - Updates

    12 Oct 2025, 5:35PM SMS Lifesciences India Limited has informed the Exchange regarding 'Report (Special Window)'.

  • SMS Lifesciences Ind - Report (Special Window)

    12 Oct 2025, 5:30PM Enclosed is summary for the month of September 2025.

  • SMS Lifesciences Ind - Shareholders meeting

    1 Oct 2025, 12:27PM SMS Lifesciences India Limited has submitted the Exchange a copy of Srutinizers report of Annual General Meeting held on September 30, 2025.

  • SMS Lifesciences Ind - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2025, 12:23PM Voting result of 19th Annual General Meeting.

  • SMS Lifesciences Ind - Shareholders meeting

    30 Sep 2025, 5:55PM SMS Lifesciences India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025

  • SMS Lifesciences Ind - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2025, 5:51PM Summary of proceedings of 19th Annual General Meeting.

  • SMS Lifesciences Ind - Updates

    29 Sep 2025, 7:02PM SMS Lifesciences India Limited has informed the Exchange regarding reappointment of Mr. TV Praveen as Managing Director in the material subsidiary.

  • SMS Lifesciences Ind - Update (Material Subsidiary)

    29 Sep 2025, 6:58PM Mr. TV Praveen was reappointed as Managing Director in the material subsidiary.

  • SMS Lifesciences Ind - Disclosure of material issue

    26 Sep 2025, 5:33PM SMS Lifesciences India Limited has informed regarding Completion of ANVISA inspection at the manufacturing facility (Unit-1) in Hyderabad.

  • SMS Lifesciences Ind - ANVISA Inspection

    26 Sep 2025, 5:27PM Completion of ANVISA inspection at the manufacturing facility (Unit 1) in Hyderabad.

  • SMS Lifesciences Ind - Trading Window

    20 Sep 2025, 11:59AM SMS Lifesciences India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula

  • SMS Lifesciences Ind - Updates

    15 Sep 2025, 6:45PM SMS Lifesciences India Limited has informed the Exchange regarding 'Special Window Report (Aug)'.

  • SMS Lifesciences Ind - Report (Special Window)

    15 Sep 2025, 6:41PM Enclosed is summary for the month of August 2025.

  • SMS Lifesciences Ind - Updates

    9 Sep 2025, 3:18PM SMS Lifesciences India Limited has informed the Exchange regarding 'Annual Report (Weblink)'.

  • SMS Lifesciences Ind - Annual Report (Weblink)

    9 Sep 2025, 3:15PM Communication to physical shareholders providing the weblink of the Annual Report F25 and AGM notice.

  • SMS Pharma receives non-exclusive license to manufacture & supply Molnupiravir

    20 Jan 2022 , 3:43PM Molnupiravir is the first oral, direct-acting antivral shown to be highly effective at reducing infectious virus
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Haleos Labs Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 276.348 264.957 249.1726 210.9553 168.1632
Liabilities 276.348 264.957 249.1726 210.9553 168.1632
Equity 3.0233 3.0233 3.0233 3.0233 3.0233
Gross Profit 44.2317 34.4313 26.4065 31.3647 29.7351
Net Profit 21.3708 13.0654 13.2176 25.3813 13.1683
Cash From Operating Activities 28.0325 14.7514 4.5753 -14.6554 21.6184
NPM(%) 6.41 4.35 4.19 7.34 5.05
Revenue 333.371 300.0016 315.2418 345.6281 260.2555
Expenses 289.1393 265.5703 288.8353 314.2634 230.5204
ROE(%) 11.38 6.95 7.03 13.51 7.01

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
1.5 15 0.11 1373.4
23 Sep 2024 1.5 15 0.11 696.3
22 Sep 2022 1.5 15 0.11 637.6
20 Sep 2021 1.5 15 0.11 659.8
19 Sep 2019 1.5 15 0.11 483.4

Peers

Other companies within the same industry or sector that are comparable to Haleos Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 784.10 -1.11 0.00 793.30 301.39 0.64
Lotus Eye Hospital and Institute Ltd 105.11 -0.51 328.47 2890.69 3.55 0.00
Vaishali Pharma Ltd 8.77 -0.23 0.00 18134.23 3.13 0.00
Astec Lifesciences Ltd 819.70 -2.17 0.00 2725.98 -604.77 0.00

Company Info

SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.

SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.

Read More

Parent Organisation

Haleos Labs Ltd.

Founded

31/05/2006

Managing Director

Mr.TVVSN Murthy

NSE Symbol

HALEOSLABSEQ

FAQ

The current price of Haleos Labs Ltd is ₹ 1390.60.

The 52-week high for Haleos Labs Ltd is ₹ 1425.00 and the 52-week low is ₹ 1375.00.

The market capitalization of Haleos Labs Ltd is currently ₹ 420.42. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Haleos Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Haleos Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Haleos Labs Ltd shares.

The CEO of Haleos Labs Ltd is Mr.TVVSN Murthy, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT